Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
08/2009
08/27/2009WO2009103652A1 Modulators for amyloid beta
08/27/2009WO2009103552A1 Substituted indole derivatives
08/27/2009WO2009082526A3 Ortho pyrrolidine, benzyl-substituted heterocycle ccr1 antagonists for autoimmune diseases & inflammation
08/27/2009WO2009012280A3 Benzimidazole poly(adp-ribose)polymerase inhibitors
08/27/2009WO2007003934A3 17beta-hydr0xyster0id dehydrogenase type 3 (17beta-hsd3 ) inhibitors
08/27/2009US20090216027 Microbiocidal (e.g. fungicidal) 1,2,3-triazole derivatives
08/27/2009US20090216023 e.g.2-(2-ethylsulfanyl-1-hydroxy-1-methyl-ethyl)-6-trifluoromethyl-(pyrimidine or pyridazine or piperazine)-pyrrole-5-carbonitrile; anticarcinogenic; prostate carcinoma, benign prostatic hyperplasia (BPH), hirsutism, alopecia, anorexia nervosa, breast cancer, acne, AIDS, cachexia, as a male contraceptive
08/27/2009US20090216014 Novel compounds and methods of treating cell proliferative diseases, retinopathies and arthritis
08/27/2009US20090215958 Conducting polymers and uses thereof
08/27/2009US20090215847 Tricyclic Angiotensin II Agonists
08/27/2009US20090215829 Thiophene carboxamides as inhibitors of the enzyme ikk-2
08/27/2009US20090215828 Substituted indole derivatives
08/27/2009US20090215827 Inhibitors of cxcr2
08/27/2009US20090215795 Cyclic amidine derivatives
08/27/2009US20090215773 Dihydropyridine derivatives
08/27/2009US20090215767 Isoflavone derivatives and pharmaceutical compositions comprising the same
08/27/2009CA2716270A1 Substituted indole derivatives
08/27/2009CA2715872A1 Benzodiazepine compound and pharmaceutical composition
08/27/2009CA2714743A1 Aryl-hydroxyethylamino-pyrimidines and triazines as modulators of fatty acid amide hydrolase
08/27/2009CA2713716A1 Modulators for amyloid beta
08/26/2009EP2091940A2 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
08/26/2009EP2091937A2 Substituted imidazoles as bombesin receptor subtype-3 modulators
08/26/2009EP2091924A1 Pyrimidine derivatives and their use as pesticides
08/26/2009EP2091916A2 L-phenylalanine derivatives and their use as integrin antagonists
08/26/2009EP1981878B1 Indazole heteroaryl derivatives
08/26/2009EP1819693B1 Antithrombotic diamides
08/26/2009EP1783116B1 2-phenylpyridine derivative
08/26/2009EP1701947B1 4-oxo-4,5-dihydro-furan-2-carboxylic and acid derivatives and methods of treatment of metabolic-related disorders thereof
08/26/2009EP1646615B1 Pyrimidine derivatives as modulators of atp-binding cassette transporters
08/26/2009EP1590338B1 Modulators of melanocortin receptor
08/26/2009EP1539700B1 8-hydroxy quinoline derivatives
08/26/2009EP1218375B1 Pharmaceutically active sulfonyl amino acid derivatives
08/26/2009CN101516871A Novel pyridazine derivatives
08/26/2009CN101516868A Novel pyridazine derivatives
08/26/2009CN101516844A 4-heteroaryl-substituted 1-aminocyclohexane-1- and cyclohexene-1-derivatives having effects on the opiod receptor system
08/26/2009CN101513402A Antiviral agent
08/26/2009CN100532374C Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders, process for their preparation and pharmaceutical compositions containing same
08/26/2009CN100532364C 5-substituted-alkylaminopyrazole derivatives as pesticides
08/25/2009US7579483 Process for preparing 7-(acryloyl)indoles
08/25/2009US7579469 For therapy of disease characterized by inflammatory, allergic, or proliferative processes
08/25/2009US7579369 CB 1 receptor inverse agonists
08/25/2009US7579366 Epothilone derivatives and their synthesis and use
08/25/2009US7579357 Antidiabetic agents; obesity; controlling appetite
08/25/2009US7579352 Retinoic acid mimetic anilides
08/25/2009US7579347 Vanilloid receptor ligands and their use in treatments
08/25/2009US7579346 Carboxamides
08/25/2009US7579340 Cardiovascular homeostasis through combination of direct neuronal control and systemic neurohormonal activation; inflammatory bowel disease
08/25/2009CA2538072C Amide-type carboxamide derivatives
08/25/2009CA2474578C Novel pyridin- and pyrimidin-derivatives
08/25/2009CA2366932C Cyclic protein tyrosine kinase inhibitors
08/25/2009CA2269246C Substituted tricyclics
08/20/2009WO2009101823A1 Branched compounds, organic thin films made by using the same, and organic thin film devices
08/20/2009WO2009101082A1 Substituted sulfonic acid amide compounds
08/20/2009WO2009101018A2 3-alkyl-piperazine derivatives and uses thereof
08/20/2009WO2009100827A1 Cycloalkoxy-substituted 4-phenyl-3,5-dicyanopyridines and use thereof
08/20/2009WO2009081105A3 Quinoxaline and quinoline derivatives as kinase inhibitors
08/20/2009WO2009037244A3 5-aryl-4,5-dihydro-(1h)-pyrazoles as cannabinoid cb1 receptor agonists
08/20/2009US20090209607 Inhibitors of akt activity
08/20/2009US20090209589 N-[(pyridin-2-yl) methoxy] hetrocyclyl carboxamide derivatives and related compounds as fungicides
08/20/2009US20090209563 Pyridinoylpiperidines as 5-HT1F agonists
08/20/2009US20090209538 Therapeutic substituted lactams
08/20/2009US20090209532 Pharmaceutical compounds
08/20/2009US20090209512 Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof
08/20/2009US20090209451 Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
08/20/2009CA2714656A1 Cycloalkoxy-substituted 4-phenyl-3,5-dicyanopyridines and use thereof
08/20/2009CA2714532A1 1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
08/20/2009CA2713378A1 3-alkyl-piperazine derivatives and uses thereof
08/19/2009EP2089385A2 Inhibitors of hepatitis c virus
08/19/2009EP2089365A1 Heterocyclic derived metalloprotease inhibitors
08/19/2009EP2088860A1 Chemokine receptor binding compounds
08/19/2009EP1838304B1 Heterocyclic aspartyl protease inhibitors
08/19/2009EP1718617B1 3-substituted 1,5-diphenylpyrazole derivatives useful as cb1 modulators
08/19/2009EP1689712B1 4-phenylpiperidine derivatives as renin inhibitors
08/19/2009EP1590334B1 2,4-diaminopyrimidine derivatives useful as inhibitors of pkc-theta
08/19/2009CN101511812A Pyrazole derivatives as cytochrome P450 inhibitors
08/19/2009CN101511792A New pyridine analogues
08/19/2009CN100528846C Amine compounds and use thereof
08/19/2009CN100528842C Diphenylazetidinone derivatives for treating disorders of the lipid metabolism
08/18/2009US7576241 e.g. 2-hydroxy-5-methoxy-N-{2-[4-[(2-thienyl(imino)methyl)amino]phenyl]ethyl)}-benzamide; nitric oxide NO-synthase enzymes inhibitor; selective or non selective traps for reactive oxygen species; antiproliferative, antiinflammatory agent
08/18/2009US7576215 Anticholesterol agents; antidiabetic agents; cardiovascular disorders ; antiarthritic agents
08/18/2009US7576209 Breast, prostate and ovarian cancer; such as 1-[4-(9-phenyl-3-pyrimidin-2-yl[1,2,4]triazolo[3,4-f]-1,6-naphthyridin-8-yl)phenyl]cyclobutanamine; serine/threonine kinase (Akt) suppression
08/18/2009US7576129 Carboxylic acid compounds
08/18/2009US7576122 Ophthalmic compositions for treating ocular hypertension
08/18/2009US7576115 1-methyl,3-alkaminothiocarbonylhydrazonomethyl,4-hydroxy,5-phenyl pyrazole; low-molecular-weight, nonpeptidic thrombopoietin receptor agonist; oral administration; bioavailability; blood disorders; platelet-increasing agents; angiogenesis; arteriosclerosis; blood/stem cell stimulant; thrombocytopenia
08/18/2009US7576111 Substituted oxazolidinones and their use in the field of blood coagulation
08/18/2009US7576107 1-(2,6-dichloro-4-trifluoromethylphenyl)-3-cyano-5-(2-methoxyethylamino)4-trifluoromethylsulfonylpyrazole; insecticides; widen the spectrum of the pesticides; control of parasites in animals
08/18/2009US7576104 4-(Aminomethyl)-2-(2,6-dioxo(3-piperidyl))isoindoline-1,3-dione hydrochloride; cytokines level reduced; tumor necrosis factor inhibitors; nontoxic; anticarcinogenic agents; antitumor agents (solid/blood-borne); cardiovascular disorders; osteoporosis; antiinflammatory agents; autoimmune diseases
08/18/2009US7576097 Crystalline form of maraviroc
08/18/2009US7576086 N1-benzyl-N4-(phenylpropane-2-yl-3-ol)piperazine; triple action on hydroxytryptamine (5-HT), noradrenalin (NA)and dopamine(DA); on brain synapses; cytochrome P-450 monooxygenase enzyme system antagonists; enzyme inhibitors; side effect reduction
08/18/2009US7576079 Viral polymerase inhibitors
08/18/2009US7576076 1-Methyl,2,6-dioxo,4-(4-(ethyloxycarbony)piperazin-1-yl-),5-(3-trifluoromethylphenyl)methyl-)-1,2,3,6-tetrahydropyrimidine; antagonist, antagonism; psychoses; antidepressants; schizophrenia; psychological disorders; Alzheimer's disease; neurodegenerative diseases;drug abuse, drug dependence (cocaine)
08/18/2009US7576063 prevention or treatment of disease associated with hyperglycemia: diabetes, impaired glucose tolerance, impaired fasting glycemia, diabetic complications or obesity; e.g. 4-[(4-{3-[1-carbamoyl-1-(methyl)-ethylcarbamoyl]propyl}-2-methylphenyl)methyl]-3-( beta -D-glucopyranosyloxy)-5-isopropyl-1H-pyrazole
08/18/2009CA2393568C Diarylmethylpiperazines
08/18/2009CA2392030C Urea compounds having muscarinic receptor antagonist activity
08/18/2009CA2392028C Carbamate derivatives having muscarinic receptor antagonist activity
08/13/2009WO2009100250A1 Chromene derivatives and use thereof as hif hydroxylase activity inhibitors
08/13/2009WO2009099982A1 2-aminopyridine kinase inhibitors
08/13/2009WO2009099133A1 Compound having carbazolyl group and use thereof
08/13/2009WO2009098901A1 3,8-diaminotetrahydroquinoline derivative
08/13/2009WO2009098282A1 Low molecular weight 2,5-disubstituted thiophene derivatives and use thereof in therapy